77 results
Page 3 of 4
6-K
EX-99.1
7aoejspg0rbtm
25 Jan 21
Special General Meeting of Shareholders
5:27pm
6-K
EX-99.1
55wrtjm r4
2 Dec 20
Therapix Biosciences to Collaborate with The University of Calgary to Further Examine its Proprietary Drug Candidate THX-160 for Pain
9:25am
424B4
9s26c9
20 Nov 20
Prospectus supplement with pricing info
4:43pm
F-1/A
spwj udt4c5yrea
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
F-1/A
2s5avvcxqdyy vtz
20 Oct 20
Registration statement (foreign) (amended)
9:57pm
6-K
EX-99.2
eermjn7atvvw0ziye kt
9 Oct 20
Interim Consolidated Financial Statements
12:00am
F-1/A
2p51j2myx0zq8xeua0c6
9 Oct 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.1
zx1 7ujvt
9 Oct 20
Interim Consolidated Financial Statements
12:00am
F-1
zn20eo 2lc
8 Sep 20
Registration statement (foreign)
5:31pm
6-K
EX-99.1
111240zel ii2r3j
23 Jun 20
Annual and Special General Meeting of Shareholders
9:06am
6-K
EX-99.2
2q9r8lbhx 6e5r0f
22 Apr 20
Therapix Biosciences Announces Appointment of New CEO
5:30pm
424B4
dyb7cv95y
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
wqz5874osk8tqsbsfo
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
u30pxg1
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
t9bufom
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
1wpimn x5
19 Mar 20
Registration statement (foreign) (amended)
12:21pm